Germany Diabetes Care Devices Market Size (2024 - 2029)

The Germany Diabetes Care Devices Market is projected to experience significant growth over the forecast period, driven by the increasing need for effective diabetes management solutions. The COVID-19 pandemic underscored the importance of addressing diabetes to prevent adverse health outcomes, as the virus was found to impact insulin secretion and glucose regulation. The market's expansion is supported by advancements in digital health technologies, which facilitate personalized chronic disease management through data collection and analysis. These technologies, including apps and automated insulin management systems, enhance patient support and outcomes, thereby improving the market's potential.

Market Size of Germany Diabetes Care Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Germany Diabetes Care Devices Market Summary
Study Period 2018 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 2.27 Billion
Market Size (2029) USD 3.05 Billion
CAGR (2024 - 2029) 6.07 %

Major Players

Germany Diabetes Care Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Germany Diabetes Care Devices Market Analysis

The Germany Diabetes Care Devices Market size is estimated at USD 2.27 billion in 2024, and is expected to reach USD 3.05 billion by 2029, growing at a CAGR of 6.07% during the forecast period (2024-2029).

The COVID-19 pandemic highlighted that substantially greater attention had to be given to diabetes to avoid unnecessary and inequitable outcomes from the infection. According to an article titled "Incidence of newly diagnosed diabetes after COVID-19," published in Diabetologia 2022, the human pancreas could also be a target of SARS-CoV-2. Following a COVID-19 infection, reduced insulin secretory granules in beta cells and impaired glucose-stimulated insulin secretion were observed. In addition, after the pandemic, some patients developed insulin resistance and had elevated blood glucose levels, although they had no previous history of diabetes.

Unusually high or low blood glucose levels can potentially lead to acute and or chronic, life-threatening conditions. Managing diabetes to improve patient outcomes requires a complex multidisciplinary approach. Appropriate and timely blood glucose monitoring allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications. Diabetes can be considered a data management disease and an example of real-world health and treatment data acquisition to inform integrated and personalized chronic disease management. Both patients and diabetes care providers continuously collect metabolic, treatment, and lifestyle data in joint decision-making on treatment—digital health technologies, including digital health applications, support diabetes self-management.

The vast range of apps in the diabetes field supports the adoption of lifestyle interventions for the prevention and management of diabetes, the evaluation of blood glucose control quality, and the dosing of insulin. Integrating blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, enhancing market prospects in future years.

Germany Diabetes Care Devices Industry Segmentation

Proper management of diabetes involves caring for the overall well-being of the body. As such, assembling a specialized team of healthcare professionals from various fields is crucial. This diabetes care team will collaborate with the patients to create a comprehensive plan for managing their condition and ensuring optimum health while also preventing any potential complications related to diabetes. The German Diabetes Care Devices Market is Segmented into Monitoring Devices (Self-monitoring Blood Glucose (Glucometer Devices, Blood Glucose Test Strips, and Lancets) and Continuous Glucose Monitoring (Sensors and Durables)) and Management Devices (Insulin Pumps (Insulin Pump Device, Insulin Pump Reservoir, ), Insulin Disposable Pens, Insulin Syringes, Cartridges in Reusable Pens, and Jet Injectors). The report offers the value (in USD) and volume (in Units) for the above segments.

By Device
By Monitoring Devices
Self-monitoring Blood Glucose
Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Durables
By Management Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable pens
Insulin Disposable Pens
Jet Injectors
By End User
Hospital/Clinics
Personal/Home
Need A Different Region Or Segment?
Customize Now

Germany Diabetes Care Devices Market Size Summary

The Germany diabetes care devices market is poised for significant growth, driven by the increasing prevalence of diabetes and advancements in technology. The market is characterized by a diverse range of devices aimed at improving diabetes management, including blood glucose monitors, insulin delivery systems, and digital health applications. These innovations are crucial in addressing the complexities of diabetes care, which requires a multidisciplinary approach to manage blood glucose levels effectively and minimize complications. The integration of digital health technologies, such as insulin calculators and remote coaching, is enhancing patient self-management and supporting better health outcomes. The market's expansion is further supported by favorable government policies and regulations that encourage the development and adoption of innovative diabetes care solutions.

The market landscape is competitive, with major players like Abbott, Medtronic, and Roche Diabetes Care leading the charge in technological advancements and research and development. These companies are focusing on creating more efficient and user-friendly devices, such as cellular-connected blood glucose meters and automated insulin delivery systems, to streamline diabetes management. The self-monitoring blood glucose segment holds a significant share of the market, reflecting the demand for easy-to-use and less invasive testing solutions. As the number of diabetes patients continues to rise, the market is expected to grow, driven by ongoing innovations and the increasing need for effective diabetes care devices in Germany.

Explore More

Germany Diabetes Care Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. Market Segmentation

    1. 2.1 By Device

      1. 2.1.1 By Monitoring Devices

        1. 2.1.1.1 Self-monitoring Blood Glucose

          1. 2.1.1.1.1 Glucometer Devices

          2. 2.1.1.1.2 Blood Glucose Test Strips

          3. 2.1.1.1.3 Lancets

        2. 2.1.1.2 Continuous Glucose Monitoring

          1. 2.1.1.2.1 Sensors

          2. 2.1.1.2.2 Durables

      2. 2.1.2 By Management Devices

        1. 2.1.2.1 Insulin Pump

          1. 2.1.2.1.1 Insulin Pump Device

          2. 2.1.2.1.2 Insulin Pump Reservoir

          3. 2.1.2.1.3 Infusion Set

        2. 2.1.2.2 Insulin Syringes

        3. 2.1.2.3 Cartridges in Reusable pens

        4. 2.1.2.4 Insulin Disposable Pens

        5. 2.1.2.5 Jet Injectors

    2. 2.2 By End User

      1. 2.2.1 Hospital/Clinics

      2. 2.2.2 Personal/Home

Germany Diabetes Care Devices Market Size FAQs

The Germany Diabetes Care Devices Market size is expected to reach USD 2.27 billion in 2024 and grow at a CAGR of 6.07% to reach USD 3.05 billion by 2029.

In 2024, the Germany Diabetes Care Devices Market size is expected to reach USD 2.27 billion.

Germany Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)